In conclusion, our study confirms IF1 as a regulator of cellular energy metabolism that favors an enhanced glycolysis in breast cancer cells but, at variance with the findings reported for IF1 in other carcinomas, it promotes the maintenance of ECM avoiding metastatic disease. The gene discussed is ATP5IF1; the disease is carcinoma.